ベーチェット病(Behcet’s Disease):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Behcet's Disease Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2368CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年9月30日
◆ページ数:79
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、世界におけるベーチェット病(Behcet's Disease)の臨床研究の最新動向について調査・分析し、アジア太平洋、欧州、北米、中南米、中東・アフリカなど各地域における治験状況、段階別の治験件数、進捗状況別の治験件数、スポンサーの種類別治験件数、有望な薬剤、治験関連ニュース、治験のプロファイル情報等をお届けします。

・イントロダクション
  - ベーチェット病(Behcet's Disease)
  - 当レポートの概要

・各地域別治験状況
  - 各国の治験件数及び平均被験者数
  - アジア太平洋の主要国における治験件数
  - 欧州の主要国における治験件数
  - 北米の主要国における治験件数
  - 中東・アフリカの主要国における治験件数
  - 中南米の主要国における治験件数
  - G7諸国での治験件数
  - G7諸国での治験件数:進捗状況別
  - E7諸国(新興7カ国)での治験件数
  - E7諸国での治験件数:進捗状況別

・段階別の治験件数
  - 進行中の治験:段階別

・進捗状況別の治験件数

・治験目標の達成状況

・未完了の治験件数

・一定期間に採用された被験者

・スポンサーの種類別治験件数

・有望なスポンサー

・有望な薬剤

・ベーチェット病(Behcet's Disease)治験関連ニュース

・治験のプロファイル
  - 主要企業の治験概要
  - 主要研究機関・病院の治験概要
  - 5つの代表的な治験のプロファイル
【レポートの概要】

Behcet’s Disease Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Behcet’s Disease Global Clinical Trials Review, H2, 2014″ provides data on the Behcet’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Behcet’s Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Behcet’s Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Behcet’s Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Behcet’s Disease to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Behcet’s Disease to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Behcet’s Disease 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Behcet’s Disease Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
XOMA Corporation 32
Clinical Trial Overview of XOMA Corporation 32
AbbVie Inc. 33
Clinical Trial Overview of AbbVie Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Celgene Corporation 35
Clinical Trial Overview of Celgene Corporation 35
Nobelpharma Co., Ltd. 36
Clinical Trial Overview of Nobelpharma Co., Ltd. 36
Mitsubishi Chemical Holdings Corporation 37
Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 37
Les Laboratoires Servier SAS 38
Clinical Trial Overview of Les Laboratoires Servier SAS 38
Clinical Trial Overview of Top Institutes / Government 39
Tehran University of Medical Sciences 39
Clinical Trial Overview of Tehran University of Medical Sciences 39
National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 40
New York University School of Medicine 41
Clinical Trial Overview of New York University School of Medicine 41
University Hospital Tubingen 42
Clinical Trial Overview of University Hospital Tubingen 42
National Eye Institute 43
Clinical Trial Overview of National Eye Institute 43
Cukurova University 44
Clinical Trial Overview of Cukurova University 44
Erasmus MC 45
Clinical Trial Overview of Erasmus MC 45
Rambam Health Care Campus 46
Clinical Trial Overview of Rambam Health Care Campus 46
Shiraz University of Medical Sciences 47
Clinical Trial Overview of Shiraz University of Medical Sciences 47
Asan Medical Center 48
Clinical Trial Overview of Asan Medical Center 48
Five Key Clinical Profiles 49
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79

List of Tables
Behcet's Disease Therapeutics, Global, Clinical Trials by Region, 2014* 7
Behcet's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Behcet's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Behcet's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Behcet's Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Behcet's Disease Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Behcet's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Behcet's Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Behcet's Disease to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Behcet's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Behcet's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Behcet's Disease to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Behcet's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Behcet's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Behcet's Disease Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Behcet's Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Behcet's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Behcet's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Behcet's Disease Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Behcet's Disease Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Behcet's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Behcet's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Behcet's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Behcet's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Behcet's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by XOMA Corporation, 2014* 32
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014* 33
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014* 35
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Nobelpharma Co., Ltd., 2014* 36
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Chemical Holdings Corporation, 2014* 37
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Laboratoires Servier SAS, 2014* 38
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2014* 39
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2014* 40
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 41
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Tubingen, 2014* 42
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 43
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cukurova University, 2014* 44
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014* 45
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2014* 46
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 47
Behcet's Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2014* 48

List of Figures
Behcet's Disease Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Behcet's Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Behcet's Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Behcet's Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Behcet's Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Behcet's Disease Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Proportion of Behcet's Disease to Immunology Clinical Trials, G7 Countries (%), 2014* 15
Behcet's Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Behcet's Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Behcet's Disease to Immunology Clinical Trials, E7 Countries (%), 2014* 18
Behcet's Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Behcet's Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Behcet's Disease Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Behcet's Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Behcet's Disease Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Behcet's Disease Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Behcet's Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Behcet's Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Behcet's Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Behcet's Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Behcet's Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 78

【レポートのキーワード】

ベーチェット病(Behcet's Disease)、治験(臨床試験)、製薬

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ベーチェット病(Behcet’s Disease):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆